$369.35
0.75% (Daily)
Market Cap
$198.99B
Revenue
$36.75B
Rank by MCap
#53
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Robert A. Bradway
Headquarters
Thousand Oaks, CA
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic a...
Loading chart…